More SEC Filings
View Older Stories View Newer Stories-
Form 40-APP/A Stellus Capital Investme
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX Vantage Point Financial For: Jun 30
-
Form 4 GSI TECHNOLOGY INC For: Aug 13 Filed by: Shu Lee-Lean
-
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 4 CTT PHARMACEUTICAL HOLDI For: Aug 12 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.
-
Form 144 OFG BANCORP Filed by: Arizmendi Maritza
-
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-Q Investcorp Credit Manage For: Jun 30
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Aug 13 Filed by: Conklin Michael
-
Form NT 10-Q AZIO AI HOLDINGS, INC. For: Jun 30
-
Form 10-Q LGL GROUP INC For: Jun 30
-
Form 8-K authID Inc. For: Aug 14
-
Form 8-K QUANTUM CORP /DE/ For: Aug 11
-
Form NT 10-Q Greenwave Technology For: Jun 30
-
Form 13F-HR Bakala Capital LLC For: Jun 30
-
Form 8-K Plum Acquisition Corp. For: Jun 03
-
Form 6-K Greenfire Resources Ltd. For: Aug 14
-
Form 1-A Deedflow INC
-
Form NT 10-Q ULIXE CORP. For: Jun 30
-
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX CARY STREET PARTNERS For: Jun 30
-
Form SCHEDULE 13G/A enVVeno Medical Corp Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX CARY STREET PARTNERS For: Jun 30
-
Form N-PX IRIDIAN ASSET MANAGEMENT For: Jun 30
-
Form 10-Q Franklin Templeton Digit For: Jun 30
-
Form 10-Q DATA I/O CORP For: Jun 30
-
Form S-1/A BIOVIE INC.
-
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-Q AIAI Holdings Corp For: Jun 30
-
Form 13F-NT Goldman Sachs Bank Europ For: Jun 30
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form NT 10-Q SeeQC, Inc. For: Jun 30
-
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: Chersi Robert J
-
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-NT EFG Private Bank Ltd For: Jun 30
-
Form 10-Q Security Midwest Bancorp For: Jun 30
-
Form 13F-NT Goldman Sachs Trust Comp For: Jun 30
-
Form 13F-HR Anatole Investment Manag For: Jun 30
-
Form 13F-NT TD SECURITIES INC For: Jun 30
-
Form 13F-HR/A Militia Capital Partners For: Dec 31
-
Form 13F-HR Medallion Wealth Advisor For: Jun 30
-
Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-Q Valuence Merger Corp. I For: Jun 30
-
Form 13F-HR Authentikos Wealth Advis For: Jun 30
-
Form 144 Krystal Biotech, Inc. Filed by: ROSSI DINO A
